Therefore, we chose breast, lung, and colon cancers; in addition, bladder cancers and lymphoma were chosen among the other cancers in which C1QBP expression was higher than in normal tissue for further systematic expression and prognosis analysis. This evidence concerns the gene C1QBP and lymphoma.